In Pain relief Walagesic 650mg/65mg Capsule is used to treat moderate to severe pain in conditions like menstrual cramp, arthritis, headache and muscle aches. It works by reducing substances in the body that causes pain. Taking Walagesic 650mg/65mg Capsule will reduce discomfort associated with the above painful conditions and make you feel better. Take Walagesic 650mg/65mg Capsule by mouth as directed by your doctor, usually every 4 to 6 hours as needed for pain relief.
It is unsafe to consume alcohol with Walagesic 650mg/65mg Capsule.
Information regarding the use of Walagesic 650mg/65mg Capsule during pregnancy is not available. Please consult your doctor.
Walagesic 650mg/65mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Even small doses of Walagesic 650mg/65mg Capsule can cause infant sleepiness and decreased/altered brain function.
It is not known whether Walagesic 650mg/65mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Walagesic 650mg/65mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Walagesic 650mg/65mg Capsule may be needed. Please consult your doctor. Use of Walagesic 650mg/65mg Capsule is not recommended in patients with end stage kidney disease.
Walagesic 650mg/65mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Walagesic 650mg/65mg Capsule may be needed. Please consult your doctor.
If you miss a dose of Walagesic 650mg/65mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Brussels Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jagsonpal Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Eli Lilly and Company India Pvt Ltd || ₹14.5/tablet (25% cheaper)